Allele Biotechnology & Pharmaceutical is a leading provider of cGMP iPSCs and cell therapy CDMO development and manufacturing services, offering a comprehensive range of solutions for immuno-oncology and regenerative medicine cell therapy programs. With over a decade of experience, they specialize in personalized iPSC approaches, delivering commercial-ready iPSCs that are consistent, scalable, and ethically sound.
Using their robust technology and proprietary mRNA system, Allele generates footprint-free, feeder-free, and xeno-free iPSCs with no risk of genomic integration, ensuring regulatory compliance and a seamless transition from scientific development to commercial deployment. As the first cGMP-grade iPSC provider in the US, Allele is dedicated to unlocking the potential of iPSCs in cell therapy, offering off-the-shelf iPSC lines and expertise in donor cell sourcing.
Generated from the website